Caxton Associates (New York)’s Synovus SNV Stock Holding History
Bought
Maintained
Sold
Other funds holding SNV
SF
Caxton Associates (New York)'s SNV Position: Q4 2024 in Review
Caxton Associates (New York) sold out of Synovus (SNV) in Q4 2024, closing a stake of 8,410 shares — an estimated $374K sold.
Caxton Associates (New York) first reported a position in SNV in Q2 2013 and held it in 14 quarters. The position peaked at $32.3M in Q2 2013. 458 funds tracked by Wall St. Rank hold SNV as of Q4 2024.
- Caxton Associates (New York) reported no remaining Synovus position as of Q4 2024 after selling out during the quarter.
- Caxton Associates (New York) sold 8,410 Synovus shares in Q4 2024, an estimated $374K.
- Caxton Associates (New York) first reported a position in Synovus in Q2 2013 and held it in 14 quarters.
- Caxton Associates (New York)'s Synovus position peaked at $32.3M in Q2 2013.
- 458 funds tracked by Wall St. Rank held Synovus as of Q4 2024.
Based on Caxton Associates (New York)'s 13F filing for Q4 2024, filed 14 Feb 2025.